ArticleESMO open2023

Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer.

C J A Punt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.